Lepu Biopharma
Lepu Biopharma is a China-based biotechnology company running 8 late-stage cancer trials of MRG003, Pucotenlimab and MRG006A in head and neck squamous cell carcinoma, nasopharyngeal carcinoma and hepatocellular carcinoma.
Overview
Lepu Biopharma, based in Shanghai, China, is a biotechnology company. Lepu Biopharma is a China-based, globally focused biopharmaceutical company developing antibody-drug conjugates, oncolytic viruses and other immunotherapies for oncology. On ClinicalTrials.gov it is the lead sponsor of 8 recruiting or active phase 2 and phase 3 interventional cancer trials (2 in phase 3), testing MRG003, Pucotenlimab, MRG006A and Cretostimogene Grenadenorepvec in head and neck squamous cell carcinoma, nasopharyngeal carcinoma, hepatocellular carcinoma and bladder & urothelial cancer. The largest, NCT06976190 (A Study of MRG003 in Combination With Pucotenlimab Versus Chemotherapy in the Treatment of Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma), plans to enrol 446 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Scorecard
All companies- phase 3 +3
- modalities +2
Similar pages
not linked directly; found by shared links- CompanySuzhou Forlong Biotechnology
Shares Bladder & urothelial cancer and the tag ctgov-sponsor.
- CompanyAscentawits Pharmaceuticals
Shares Hepatocellular carcinoma and the tag ctgov-sponsor.
- CompanyCatalYm
Shares Hepatocellular carcinoma and the tag ctgov-sponsor.
- CompanyShanghai AbelZeta
Shares Hepatocellular carcinoma and the tag ctgov-sponsor.
- CompanyAveta Biomics
Shares Head and neck squamous cell carcinoma and the tag ctgov-sponsor.
- CompanyQBiotics
Shares Head and neck squamous cell carcinoma and the tag ctgov-sponsor.
- CompanyRakuten Medical
Shares Head and neck squamous cell carcinoma and the tag ctgov-sponsor.
- CompanyAP Biosciences
Shares Head and neck squamous cell carcinoma and the tag ctgov-sponsor.